International Journal of Hematology

, Volume 76, Supplement 2, pp 36–39 | Cite as

Targeted gene disruption of natural anticoagulant proteins in mice

  • Tetsuhito Kojima
Update on Hypercoagulability


The blood coagulation system is a complicated cascade of reactions and feedback regulations that executes a rapid response to vascular injury, yet avoids occlusion of the vessel. There are several key components of this system in the regulation of blood clot propagation, such as antithrombin (AT), tissue factor pathway inhibitor (TFPI), thrombomodulin (TM) and protein C (PC), of which defect causes thromboembolic diseases. In recent years, targeted gene disruption technique by homologous recombination has been introduced to investigate the physiological roles of those natural anticoagulant molecules, not only in thrombogenesis but also in embyrogenesis. We have studied the natural anticoagulantion system in a decade, and recently established AT knockout mice as well as ryudocan (syndecan-4) knockout mice. Ryudocan is a cell surface heparan sulfate proteoglycan, which bears heparin-like glycosaminoglycan (heparan sulfate) cahins, orginally cloned from rat microvascular endothelial cells. We have demonstrated that ryudocan deficiency impairs the control of coagulation in fetal vessels of the placenta in mice. We have also reported that complete antithrombin deficiency in mice results in embryonic lethality, with severe fibrin deposition in the myocardium and the liver, accompanied with extensive subcutaneous hemorrhage. In this presentation, recent advances in understanding roles of natural anticoagulant molecules through the researches of targeted gene-knockout mice, including our experiences in antithrombin deficient mice and ryudocan deficient mice, will be discussed.


Heparan Sulfate Antithrombin Deficient Mouse Embryonic Lethality Tissue Factor Pathway Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rosenberg RD, Aird WC. Vascular-bed-specific hemostatsis and hypercoagulable state.New Engl J Med. 1999;340:1555–1156.PubMedCrossRefGoogle Scholar
  2. 2.
    Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.Proc Natl Acad Sci USA. 1995;92:850–854.PubMedCrossRefGoogle Scholar
  3. 3.
    Huang ZF, Higuchi D, Lasky N, Broze GJ, Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.Blood. 1997;90:944–951.PubMedGoogle Scholar
  4. 4.
    Jalbert LR, Rosen ED, Moons L, Chan JC, Carmeliet P, Collen D, Castellino FJ. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.J Clin Invest. 1998;102:1481–1488.PubMedCrossRefGoogle Scholar
  5. 5.
    Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality.J Clin Invest. 2000;106:873–878.PubMedCrossRefGoogle Scholar
  6. 6.
    Yanada M, Kojima T, Ishiguro K, et al. The impact of antithrombin deficiency in thrombogenesis: LPS and stress-induced thrombus formation in heterozygous antithrombin deficient mice.Blood. 2002;99:2455–2458.PubMedCrossRefGoogle Scholar
  7. 7.
    Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions.J Biol Chem. 2000;275:5249–5252.PubMedCrossRefGoogle Scholar
  8. 8.
    Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth.Dev Dyn. 2000;219:539–544.PubMedCrossRefGoogle Scholar
  9. 9.
    Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage.Lab Invest. 2001;81:509–516.PubMedGoogle Scholar
  10. 10.
    Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice.J Biol Chem. 2001;276:47483–47488.PubMedCrossRefGoogle Scholar
  11. 11.
    Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor.J Biol Chem. 1973;248:6490–6505.PubMedGoogle Scholar
  12. 12.
    Blajchman MA, Austin RC, Fernandez-Rachubinski F, Sheffield WP. Molecular basis of inherited human antithrombin deficiency.Blood. 1992;80:2159–2171.PubMedGoogle Scholar
  13. 13.
    Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.Annu Rev Cell Biol. 1992;8:365–393.PubMedCrossRefGoogle Scholar
  14. 14.
    Kojima T, Shworak NW, Rosenberg RD Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.J Biol Chem. 1992;267:4870–4877.PubMedGoogle Scholar
  15. 15.
    Kojima T, Leone CW, Marchildon GA, Marcum JA, Rosenberg RD. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.J Biol Chem. 1992;267:4859–4869.PubMedGoogle Scholar
  16. 16.
    Berg DJ, Kuhn R, Rajewsky K, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.J Clin Invest. 1995;96:2339–2347.PubMedCrossRefGoogle Scholar
  17. 17.
    Imai K, Takeshita A, Hanazawa S. Transforming growth factor-beta inhibits lipoplyssaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression.Infect Immun. 2000;68:2418–2423.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Tetsuhito Kojima
    • 1
  1. 1.Nagoya University School of Health SciencesJapan

Personalised recommendations